WASHINGTON, DC / ACCESSWIRE / October 1, 2024 / Boosting research investment into the health and wellbeing of adults with Down syndrome would improve quality-of-life outcomes, reduce the costs of ...

From biochemist to executive supplier to angel investor to company founder and CEO, Maria Maccecchini, Ph.D.’s ...

Alzheimer's disease (AD) has become a focal point in the pharmaceutical industry as recent drugs such as Leqembi and Kisunla have received ...

Medical meetings often feature important clinical trial results, making them barometers of biotech and pharma companies' research progress. Here’s a list of conferences to watch in 2025.

The company is set to become the first $1tn drugmaker, but investors see warning signs it has reached ‘peak enthusiasm’ ...

Annovis is at the forefront, testing buntanetap in pivotal clinical trials as a therapy for Alzheimer's and Parkinson's diseases (PD). Company has filed three new patents protecting combinations of ...

Speaker Mike Johnson is blasting Democrats for being “hypocritical” when it comes to standing with Israel after Iran’s ballistic missile attacks on Tuesday. The GOP leader kicked off a ...

Legislators in Kenya have started the process of removing the country's deputy president from office. Africans studying in Beirut are having to weigh up whether or not they should leave the ...

The attack, which ended shortly after it began, capped a chaotic 24-hour period that began with Israel’s invading of Lebanon in pursuit of Hezbollah. Iran fired a barrage of ballistic missiles ...

Rescue workers searched for survivors in the mountains of western North Carolina on Tuesday, trying to contact and deliver aid to hundreds of people cut off by washed-out roads, felled power lines ...

Mark Zuckerberg is quickly climbing the ranks of the world's richest people, joining the $200 billion net worth club. Bloomberg’s Billionaire Index figures suggest that the Meta CEO's wealth has ...